Psychotic Depression
8
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
50%
4 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
The Efficacy of Metacognitive Skills Training in the Context of Forensic Psychiatric Care
Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)
Voxel Based Morphometry In Patients With Psychotic Versus Non Psychotic Depression
Sustaining Remission of Psychotic Depression
A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
Quetiapine in the Treatment of Psychotic Depression - a Pilot Study
The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
Recovery Guide Intervention for Recurrent Psychiatric Hospitalization